Direct serum and tissue assay for EGFR mutation in non-small cell lung cancer by high-resolution melting analysis

Oncology Reports

Volumn 28, Issue 5, 2012, Pages 1815-1821

  Hu, Chengjin ^a   Liu, Xiaolei ^a   Chen, Yingjian ^a   Sun, Xiaoming ^a   Gong, Yanwen ^a   Geng, Ming ^a   Bi, Liquan ^a  

^a JINAN MILITARY GENERAL HOSPITAL   (China)

Author keywords

Epidermal growth factor receptor; High resolution melting; Mutation; Non small cell lung carcinoma

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; EPIDERMAL GROWTH FACTOR RECEPTOR TYROSINE KINASE GENE; EXON; FEASIBILITY STUDY; FEMALE; GENE IDENTIFICATION; GENE MUTATION; GENETIC SCREENING; HIGH RESOLUTION MELTING ANALYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG CARCINOGENESIS; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MOLECULAR PATHOLOGY; MUTATION RATE; ONCOGENE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RELIABILITY; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS;

AGED; CARCINOMA, NON-SMALL-CELL LUNG; DNA PRIMERS; DNA, NEOPLASM; FEMALE; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; INDIVIDUALIZED MEDICINE; LUNG NEOPLASMS; MALE; MIDDLE AGED; MUTATION; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 84866437399     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2012.1987     Document Type: Article

References (36)

1. Sasaki H, Endo K, Konishi A, et al: EGFR mutation status in Japanese lung cancer patients: genotyping analysis using LightCycler. Clin Cancer Res 11: 2924-2929, 2005. (Pubitemid 40525194)
2. Nicholson RI, Gee JM and Harper ME: EGFR and cancer prognosis. Eur J Cancer 37 (Suppl 4): S9-S15, 2001. (Pubitemid 32938124)
3. Ohsaki Y, Tanno S, Fujita Y, et al: Epidermal growth factor receptor expression correlates with poor prognosis in non-small cell lung cancer patients with p53 overexpression. Oncol Rep 7: 603-607, 2000.
4. Scaltriti M and Baselga J: The epidermal growth factor receptor pathway: a model for targeted therapy. Clin Cancer Res 12: 5268-5272, 2006. (Pubitemid 44497237)
5. Lynch TJ, Bell DW, Sordella R, et al: Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med 350: 2129-2139, 2004. (Pubitemid 38637993)
6. Paez JG, Janne PA, Lee JC, et al: EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science 304: 1497-1500, 2004. (Pubitemid 38720929)
7. Shigematsu H, Lin L, Takahashi T, et al: Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers. J Natl Cancer Inst 97: 339-346, 2005. (Pubitemid 40425952)
8. Borras E, Jurado I, Hernan I, et al: Clinical pharmacogenomic testing of KRAS, BRAF and EGFR mutations by high resolution melting analysis and ultra-deep pyrosequencing. BMC Cancer 11: 406-415, 2011.
9. Yasuda H, Kobayashi S and Costa DB: EGFR exon 20 insertion mutations in non-small-cell lung cancer: preclinical data and clinical implications. Lancet Oncol 13: e23-e31, 2011.
10. Murray S, Dahabreh IJ, Linardou H, Manoloukos M, Bafaloukos D and Kosmidis P: Somatic mutations of the tyrosine kinase domain of epidermal growth factor receptor and tyrosine kinase inhibitor response to TKIs in non-small cell lung cancer: an analytical database. J Thorac Oncol 3: 832-839, 2008.
11. Linardou H, Dahabreh IJ, Bafaloukos D, Kosmidis P and Murray S: Somatic EGFR mutations and efficacy of tyrosine kinase inhibitors in NSCLC. Nat Rev Clin Oncol 6: 352-366, 2009.
12. Han SW, Kim YT, Hwang PG, et al: Predictive and prognostic impact of epidermal growth factor receptor mutation in non-small-cell lung cancer patients treated with gefitinib. J Clin Oncol 23: 2493-2501, 2005.
13. Carey KD, Garton AJ, Romero MS, et al: Kinetic analysis of epidermal growth factor receptor somatic mutant proteins shows increased sensitivity to the epidermal growth factor receptor tyrosine kinase inhibitor, erlotinib. Cancer Res 66: 8163-8171, 2006. (Pubitemid 44299184)
14. Sriram KB, Tan ME, Savarimuthu SM, et al: Screening for activating EGFR mutations in surgically resected nonsmall cell lung cancer. Eur Respir J 10: 455-465, 2011.
15. Taylor CF: Mutation scanning using high-resolution melting. Biochem Soc Trans 37: 433-437, 2009.
16. Stroun M, Anker P, Maurice P, Lyautey J, Lederrey C and Beljanski M: Neoplastic characteristics of the DNA found in the plasma of cancer patients. Oncology 46: 318-322, 1989. (Pubitemid 19216753)
17. Sorenson GD, Pribish DM, Valone FH, Memoli VA, Bzik DJ and Yao SL: Soluble normal and mutated DNA sequences from single copy genes in human blood. Cancer Epidemiol Biomarkers Prev 3: 67-71, 1994.
18. Vasioukhin V, Anker P, Maurice P, Lyautey J, Lederrey C and Stroun M: Point mutations of the N-ras gene in the blood plasma DNA of patients with myelodysplastic syndrome or acute myelogenous leukaemia. Br J Haematol 86: 774-779, 1994. (Pubitemid 24194434)
19. NCBI/BLAST: http://blast.ncbi.nlm.nih.gov/Blast.cgi.
20. Horn L and Pao W: EML4-ALK: Honing in on a new target in non-small-cell lung cancer. J Clin Oncol 27: 4232-4235, 2009.
21. Choi YL, Soda M, Yamashita Y, et al: EML4-ALK mutations in lung cancer that confer resistance to ALK inhibitors. N Engl J Med 363: 1734-1739, 2010.
22. Pao W and Girard N: New driver mutations in non-small-cell lung cancer. Lancet Oncol 12: 175-180, 2011.
23. Sequist LV, Bell DW, Lynch TJ and Haber DA: Molecular predictors of response to epidermal growth factor receptor antagonists in non-small-cell lung cancer. J Clin Oncol 25: 587-595, 2007. (Pubitemid 350002967)
24. Uramoto H and Mitsudomi T: Which biomarker predicts benefit from EGFR-TKI treatment for patients with lung cancer? Br J Cancer 96: 857-863, 2007. (Pubitemid 46452294)
25. Jackman DM, Yeap BY, Sequist LV, et al: Exon 19 deletion mutations of epidermal growth treated with gefitinib or erlotinib. Clin Cancer Res 12: 3908-3914, 2006.
26. Riely GJ, PaoW, Pham D, et al: Clinical course of patients with non-small cell lung cancer and epidermal growth factor receptor exon 19 and exon 21 mutations treated with gefitinib or erlotinib. Clin Cancer Res 12: 839-844, 2006. (Pubitemid 43259866)
27. Mitsudomi T, Kosaka T, Endoh H, et al: Mutations of the epidermal growth factor receptor gene predict prolonged survival after gefitinib treatment in patients with non-small cell lung cancer with postoperative recurrence. J Clin Oncol 23: 2513-2520, 2005. (Pubitemid 47050841)
28. Pao W and Ladanyi M: Epidermal growth factor receptor mutation testing in lung cancer: searching for the ideal method. Clin Cancer Res 13: 4954-4955, 2007. (Pubitemid 47502057)
29. Bosquet JG, Calcei J, Wei JS, et al: Detection of somatic mutations by high-resolution DNA melting (HRM) analysis in multiple cancers. PLoS One 6: e14522, 2011.
30. Nomoto K, Tsuta K, Takano T, et al: Detection of EGFR mutations in archived cytologic specimens of non-small cell lung cancer using high resolution melting analysis. Am J Clin Pathol 126: 608-615, 2006. (Pubitemid 44498512)
31. Camila GC and Mauricio RL: The use of high-resolution melting analysis for genotyping Symbiodinium strains: a sensitive and fast approach. Mol Ecol Resour 11: 394-399, 2011.
32. Sriram KB, Tan ME, Savarimuthu SM, et al: Screening for activating EGFR mutations in surgically resected nonsmall cell lung cancer. Eur Respir J 38: 903-910, 2011.
33. Takano T, Ohe Y, Tsuta K, et al: Epidermal growth factor receptor mutation detection using high-resolution melting analysis predicts outcomes in patients with advanced non small cell lung cancer treated with gefitinib. Clin Cancer Res 18: 5385-5390, 2007. (Pubitemid 47510364)
34. Bell DW, Lynch TJ, Haserlat SM, et al: Epidermal growth factor receptor mutations and gene amplification in non-small-cell lung cancer: molecular analysis of the IDEAL/INTACT gefitinib trials. J Clin Oncol 23: 8081-8092, 2005. (Pubitemid 46657411)
35. Sharma SV, Bell DW, Settleman J and Haber DA: Epidermal growth factor receptor mutations in lung cancer. Nat Rev Cancer 7: 169-181, 2007.
36. Smith GD, Chadwick BE, Willmore-Payne C and Bentz JS: Detection of epidermal growth factor receptor gene mutations in cytology specimens from patients with non-small cell lung cancer utilising high-resolution melting amplicon analysis, J Clin Pathol 61: 487-493, 2008. (Pubitemid 351518232)